10 Online GLP-1 Providers Worth Trusting in 2026, Ranked by What Actually Matters

The GLP-1 telehealth space is crowded, loosely regulated, and full of brands that look identical until something goes wrong.

The GLP-1 category changed quickly in 2026. Regulatory pressure increased, several telehealth brands reworked their compounded-medication offerings, and newer oral options made yesterday’s comparison charts less useful.

Best for Cash-Pay Value with Verified Pharmacy Standards

1. HealthRX

Compounded semaglutide at $99 per month and tirzepatide at $149 per month puts HealthRX at the low end of what any supervised telehealth program charges for these medications. The price alone would not be enough. What earns the top cash-pay spot is the specificity of its supply chain.

Medications are dispensed through Manifest Pharmacy in Greer, South Carolina, a named 503A compounding pharmacy operating under USP-797 standards with lot-level tracking from preparation to delivery. That kind of traceability is not universal in this space. HealthRX also carries LegitScript certification (certificate 50087439), which requires ongoing review. A US board-certified physician reviews each assessment within roughly 24 hours, and free overnight shipping covers all 50 states.

Worth stating plainly: these are compounded medications, not FDA-approved drugs. The weight-loss figures HealthRX references come from published trials, specifically SURMOUNT-1 (tirzepatide, approximately 21% body weight reduction at 72 weeks) and STEP 1 (semaglutide, approximately 15% at 68 weeks), not from HealthRX’s own patient outcomes.

Best for: cash-pay patients who want low monthly pricing and a verifiable, named pharmacy behind their prescription.

Best for Published Purity Testing or a Broader Peptide Catalog

2. FormBlends

FormBlends operates under a similar compounded GLP-1 model with physician oversight, but it earns its spot for a different reason. It publishes per-batch purity documentation: HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin and sterility results. The overwhelming majority of GLP-1 telehealth platforms skip this step entirely.

Pricing is higher. Semaglutide runs around $299 per vial and tirzepatide around $349, so the monthly cost will exceed HealthRX’s entry pricing for most patients. Shipping reaches 47 states rather than 50. The broader appeal is for someone who also wants access to a peptide catalog covering recovery, longevity, or cognitive-focused compounds under the same clinician framework. FormBlends is dispensed through an FDA-registered 503A pharmacy.

Best for: patients who want documented, published purity data or who plan to use GLP-1s alongside other peptides from one provider.

Best After Insurance Coverage

3. Hims & Hers

Hims & Hers exited compounded semaglutide after the Novo settlement in March 2026. The platform now focuses on branded medications: injectable Wegovy at roughly $299 per month, oral options around $249, and Zepbound near $399. With qualifying insurance and manufacturer savings cards, out-of-pocket costs can drop to $0 to $25 per month. That math is hard to beat for anyone with coverage. Without insurance, the sticker price is steep.

4. Ro Body

Ro’s first month runs about $39, then $74 to $149 monthly for the platform, with medications billed separately. A dedicated prior-authorization team works to get branded drugs covered by insurance. For patients willing to work through that process, Ro is one of the more organized options for landing on a branded prescription at a manageable cost.

5. PlushCare

PlushCare charges about $19.99 per month for membership, accepts insurance, and offers same-day appointments. It focuses on branded medications. Thin on coaching but strong on access speed and insurance compatibility.

Best for Medical Monitoring and Obesity-Medicine Credentials

6. Mochi Health

Mochi is the pick for patients who want board-certified obesity-medicine clinicians, not just a general practitioner sign-off. Compounded semaglutide starts around $99 per month and tirzepatide around $199. Monitoring is more hands-on than most platforms at this price range.

*A quick honest note: no telehealth-only provider replaces in-person metabolic monitoring. Anyone with cardiovascular history, kidney disease, or a complex medication list should loop in a local physician regardless of which platform they choose.*

7. Form Health

Premium tier. Around $299 per month and that covers a physician plus a registered dietitian working as a team, with labs included. Medication costs are separate. It is the most clinical non-hospital option on this list, which matters for patients who’ve failed multiple prior attempts and need structured accountability.

Best Budget and Flexible Options

8. Henry Meds

Cash-pay compounded medications at roughly $179 to $249 for the first month, shipping within 24 to 72 hours. Light on coaching but fast and affordable.

9. Sesame

Annual membership starts around $59 per month. Medications are billed separately. Sesame is a general telehealth marketplace, not a dedicated weight-loss program, which means visit quality can vary by clinician.

10. Found

About $99 per month for the platform plus medication costs. Found includes coaching and prescribes across multiple medication classes, not just GLP-1s, which is useful if a GLP-1 is not the right fit.

A Note on the Broader Field

MEDVi, Eden, Calibrate, Ivim Health, TrimRx, and WeightWatchers Clinic are all real operating platforms with varying price points and pharmacy arrangements. None had disqualifying public red flags at time of writing, but none offered a clear differentiator strong enough to break into this list ahead of the ten above.

Oral orforglipron, Lilly’s non-peptide GLP-1 pill, became available via LillyDirect around April 2026 at approximately $149 per month. That may reshape the branded-medication tier significantly over the next year.

Common Questions

Does LegitScript certification actually mean a GLP-1 telehealth provider is safe?

LegitScript certification is a meaningful signal, not a guarantee. It requires ongoing review of prescribing practices and pharmacy sourcing, which filters out the worst actors. HealthRX holds certificate 50087439. That said, certification does not verify individual batch quality or clinical outcomes, so it works best as one checkpoint among several.

What happened to compounded semaglutide after the Novo Nordisk settlement in March 2026?

The settlement accelerated a shift already underway. Several major platforms, including Hims & Hers, stopped offering compounded semaglutide and moved to branded medications only. Providers like HealthRX and Mochi Health that use 503A pharmacies continued operating, but the regulatory pressure on compounders increased noticeably from that point forward.

Is there a real difference between a 503A and a 503B compounding pharmacy for GLP-1 patients?

Yes, and it matters. A 503A pharmacy compounds for individual patients under a specific prescription. A 503B outsourcing facility can produce larger batches without patient-specific prescriptions and faces FDA inspections more like a manufacturer. Neither automatically means higher quality, but knowing which type your provider uses tells you something about how your medication was made and stored.

How do FormBlends and HealthRX compare for someone who just wants the cheapest verified option?

HealthRX wins on price. Semaglutide at $99 per month versus FormBlends at roughly $299 per vial is a significant gap. FormBlends earns its higher cost through published batch-level purity data, including HPLC and mass spectrometry results, which HealthRX does not publicly provide in the same format. Budget-first patients with no special testing concerns will likely do better at HealthRX.

Which providers on this list are realistic if a patient has insurance and wants branded Wegovy or Zepbound?

Hims & Hers, Ro Body, and PlushCare are the three built around that path. Ro has a dedicated prior-authorization team, which is useful if your insurer pushes back. PlushCare offers same-day appointments and accepts insurance directly. Hims & Hers pairs manufacturer savings cards with insurance, which can bring monthly costs down to $0 to $25 for qualifying patients.

Sources

• FDA warning letters to compounding facilities, 2026 (FDA.gov official releases)
• Novo Nordisk settlement announcement, March 9, 2026 (public press statements)
• SURMOUNT-1 trial results, *New England Journal of Medicine*, 2022
• STEP 1 trial results, *New England Journal of Medicine*, 2021
• LillyDirect orforglipron pricing, Eli Lilly public announcement, April 2026
• LegitScript certification database (LegitScript.com, public search)
• Individual provider pricing sourced from publicly listed plan pages, verified Q2 2026